Chat with GenHealth to automate any coding or chart task.
Name of the Condition
- Anemia due to other disorders of glycolytic enzymes
Summary
Anemia due to other disorders of glycolytic enzymes is a hemolytic anemia caused by deficiencies in enzymes involved in the glycolytic pathway, which is critical for red blood cell energy production. These deficiencies impair the cell's ability to maintain structural integrity and function, leading to premature destruction of red blood cells. This results in reduced oxygen-carrying capacity and symptoms of anemia.
Causes
The condition arises from genetic mutations that reduce or eliminate the activity of specific glycolytic enzymes, such as pyruvate kinase or phosphofructokinase. These enzymes are essential for red blood cell metabolism and survival. The mutations are typically inherited and may be exacerbated by environmental triggers that increase metabolic stress.
Risk Factors
- Genetic predisposition (inherited glycolytic enzyme deficiencies)
- Exposure to oxidative stressors (e.g., certain medications, infections, or chemicals)
- Family history of hemolytic anemia
- Underlying metabolic disorders affecting glycolytic pathways
Symptoms
- Fatigue and weakness
- Pale skin or jaundice
- Shortness of breath
- Dark urine (in acute hemolysis)
- Rapid heart rate
- Enlarged spleen (splenomegaly)
Diagnosis
Diagnosis involves blood tests to assess red blood cell count, hemoglobin levels, and reticulocyte count, along with specific enzyme activity assays to identify the underlying glycolytic enzyme deficiency. Additional tests may include genetic testing to confirm mutations and rule out other causes of hemolytic anemia.
Treatment Options
Treatment focuses on managing symptoms and addressing the underlying enzyme deficiency. Options may include blood transfusions for severe anemia, folic acid supplementation to support red blood cell production, and avoiding triggers that exacerbate hemolysis. In some cases, splenectomy may be considered to reduce red blood cell destruction.
Prognosis and Follow-Up
Prognosis varies depending on the severity of the enzyme deficiency and response to treatment. Regular follow-up with a hematologist is recommended to monitor anemia, adjust therapies, and address complications. Lifelong management may be necessary for individuals with chronic hemolysis.
Complications
- Severe anemia requiring transfusions
- Gallstones (from chronic hemolysis)
- Iron overload (from repeated transfusions)
- Splenomegaly or splenic rupture
- Developmental delays (in severe cases)
Lifestyle & Prevention
- Avoid known oxidative stressors (e.g., certain medications, infections)
- Maintain a balanced diet rich in folic acid
- Stay hydrated and manage fatigue with rest
- Follow up regularly with healthcare providers to monitor condition
When to Seek Professional Help
Seek immediate medical attention if experiencing severe fatigue, shortness of breath, dark urine, or signs of jaundice. Regular check-ups are recommended for ongoing management of hemolytic anemia.
Tips for Medical Coders
Document the specific glycolytic enzyme deficiency (e.g., pyruvate kinase, phosphofructokinase) when available, as this supports accurate coding. Ensure clinical documentation aligns with the diagnosis and includes details on enzyme activity testing or genetic confirmation to justify the use of D55.29.
D55.29 policy automation walkthrough
Walk through the policies, prior authorization requirements, and workflow automation opportunities connected to this code.